SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950129-08-000154
Filing Date
2008-01-10
Accepted
2008-01-10 17:17:35
Documents
4
Period of Report
2008-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K - CURRENT REPORT h53038ae8vk.htm 8-K 29198
2 FOURTH AMENDMENT TO RIGHTS AGREEMENT h53038aexv4w5.htm EX-4.5 11132
3 STANDSTILL AGREEMENT h53038aexv10w1.htm EX-10.1 35616
4 PRESS RELEASE h53038aexv99w1.htm EX-99.1 8138
  Complete submission text file 0000950129-08-000154.txt   85940
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15281 | Film No.: 08524309
SIC: 2836 Biological Products, (No Diagnostic Substances)